Identification |
Name: | 2(1H)-Quinolinone,5-[3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]-3,4-dihydro-, hydrochloride(1:1) |
Synonyms: | 2(1H)-Quinolinone,5-[3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]-3,4-dihydro-,monohydrochloride (9CI);5-(3-tert-Butylamino-2-hydroxy)propoxy-3,4-dihydrocarbostyril hydrochloride;Arteoptic; Caltidren; Carteol; Carteolol hydrochloride; Cartrol; Endak;Mikelan; NSC 300906; OC 1085; OPC 1085; Ocupress; Optipress; Tenalet; Tenalin;Teoptic; dl-Carteolol hydrochloride |
CAS: | 51781-21-6 |
EINECS: | 257-415-7 |
Molecular Formula: | C16H24 N2 O3 . Cl H |
Molecular Weight: | 328.88 |
InChI: | InChI=1/C16H24N2O3.ClH/c1-16(2,3)17-9-11(19)10-21-14-6-4-5-13-12(14)7-8-15(20)18-13;/h4-6,11,17,19H,7-10H2,1-3H3,(H,18,20);1H |
Molecular Structure: |
|
Properties |
Flash Point: | 267.4°C |
Boiling Point: | 518.6°Cat760mmHg |
Density: | 1.13g/cm3 |
Specification: | Crystalline Solid usageEng:-Adrenergic blocker. Antihypertensive; antianginal; antiarrhythmic; antiglaucoma |
Report: |
EPA Genetic Toxicology Program.
|
Flash Point: | 267.4°C |
Storage Temperature: | Refrigerator |
Usage: | -Adrenergic blocker. Antihypertensive; antianginal; antiarrhythmic; antiglaucoma |
Safety Data |
|
|